BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Binquan Wu, Amin Li, Yinci Zhang, Xueke Liu, Shuping Zhou, Huaiyong Gan, Shiyu Cai, Yong Liang, Xiaolong Tang. Resistance of hepatocellular carcinoma to sorafenib can be overcome with co-delivery of PI3K/mTOR inhibitor BEZ235 and sorafenib in nanoparticlesExpert Opinion on Drug Delivery 2020; 17(4): 573 doi: 10.1080/17425247.2020.1730809